Sofie
VA - DullesPharmaceutical
Focus: Sofie is a specialized radiopharmaceutical company focused on PET imaging probes and radiochemical synthesis, with expertise in oncology, rare diseases, and infectious disease diagnostics. The company operates from Dulles, VA with a niche but clinically significant product portfolio.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Sofie
AI assessmentNot HiringNo open roles listed right now. Follow Sofie to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Fludeoxyglucose F-18
Stable
Post-LOE
Foundational PET imaging agent for oncology and neurology; multiple ANDA approvals indicate strong market footprint despite patent expiration.
Help build intelligence for Sofie
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.